Latest period
$1.16B
YoY change
+33.9%
5Y CAGR
-14.0%
Peak year (2018)
$3.51B
Latest annual
$1.63B
Cash on Hand history chart for Illumina (ILMN) from 1999 to 2025
Latest: $1.63B
Cash on Hand growth chart for Illumina (ILMN) from 1999 to 2025
Latest: +33.9%
Cash on Hand history table for Illumina (ILMN) from 1999 to 2025
| 2025 | $1.63B | +33.9% | +$413.00M | ||
| 2024 | $1.22B | +15.7% | +$166.00M | ||
| 2023 | $1.05B | -48.3% | −$983.00M | ||
| 2022 | $2.04B | +52.1% | +$698.00M | ||
| 2021 | $1.34B | -61.4% | −$2.13B | ||
| 2020 | $3.47B | +1.7% | +$58.00M | ||
| 2019 | $3.41B | -2.8% | −$98.00M | ||
| 2018 | $3.51B | +63.7% | +$1.37B | ||
| 2017 | $2.15B | +37.6% | +$586.28M | ||
| 2016 | $1.56B | +12.4% | +$172.50M | ||
| 2015 | $1.39B | +3.6% | +$47.85M | ||
| 2014 | $1.34B | +14.8% | +$172.77M | ||
| 2013 | $1.17B | -13.7% | −$184.60M | ||
| 2012 | $1.35B | +13.5% | +$160.64M | ||
| 2011 | $1.19B | +33.0% | +$295.28M | ||
| 2010 | $894.29M | +28.9% | +$200.76M | ||
| 2009 | $693.53M | +8.4% | +$53.45M | ||
| 2008 | $640.08M | +65.8% | +$253.99M | ||
| 2007 | $386.08M | +195.2% | +$255.28M | ||
| 2006 | $130.80M | +157.4% | +$79.98M | ||
| 2005 | $50.82M | -7.2% | −$3.97M | ||
| 2004 | $54.79M | +67.1% | +$22.01M | ||
| 2003 | $32.78M | -39.0% | −$20.98M | ||
| 2002 | $53.76M | -40.6% | −$36.73M | ||
| 2001 | $90.49M | -22.7% | −$26.61M | ||
| 2000 | $117.10M | +253.9% | +$84.01M | ||
| 1999 | $33.09M | — | — |
- 2025$1.63B+33.9%
- 2024$1.22B+15.7%
- 2023$1.05B-48.3%
- 2022$2.04B+52.1%
- 2021$1.34B-61.4%
- 2020$3.47B+1.7%
- 2019$3.41B-2.8%
- 2018$3.51B+63.7%
- 2017$2.15B+37.6%
- 2016$1.56B+12.4%
- 2015$1.39B+3.6%
- 2014$1.34B+14.8%
- 2013$1.17B-13.7%
- 2012$1.35B+13.5%
- 2011$1.19B+33.0%
- 2010$894.29M+28.9%
- 2009$693.53M+8.4%
- 2008$640.08M+65.8%
- 2007$386.08M+195.2%
- 2006$130.80M+157.4%
- 2005$50.82M-7.2%
- 2004$54.79M+67.1%
- 2003$32.78M-39.0%
- 2002$53.76M-40.6%
- 2001$90.49M-22.7%
- 2000$117.10M+253.9%
- 1999$33.09M—
Cash on Hand values are taken from Illumina's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Cash on Hand at Illumina (ILMN)
According to Illumina's latest reported financial statements, the company's latest reported cash and short-term investments is $1.16B. Cash on hand here is cash, cash equivalents, and short-term investments reported at the end of each period — the most liquid assets on the balance sheet. Compare with total debt for net leverage and total assets for the share of assets held in cash.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
2025's annual cash and short-term investments for Illumina (ILMN) came in at $1.63B – surged 33.9% year-over-year.
Illumina cash and short-term investments compound annual growth for the 2020–2025 (5 years) window is -14.0%, sustaining 2 straight years of year-over-year growth.
Between 2018 and 2025, Illumina cash and short-term investments plunged 53.5%, falling from $3.51B to $1.63B.
2018 marks the peak cash and short-term investments at $3.51B, with the historical low of $32.78M recorded in 2003.
Illumina Cash on Hand by Year
Illumina Cash on Hand 2025: $1.63B
2025's cash and short-term investments for Illumina came in at $1.63B, surged 33.9% from 2024.
Illumina Cash on Hand 2024: $1.22B
Illumina posted cash and short-term investments of $1.22B in 2024, grew 15.7% from 2023.
Illumina Cash on Hand 2023: $1.05B
In 2023, Illumina reported cash and short-term investments of $1.05B, plunged 48.3% below 2022.
Illumina Cash on Hand 2022: $2.04B
Illumina cash and short-term investments in 2022 was $2.04B, surged 52.1% from 2021.
Illumina Cash on Hand 2021: $1.34B
Illumina cash and short-term investments in 2021 was $1.34B.
See more financial history for Illumina (ILMN).
Sector peers by Cash on Hand
Healthcare peers of Illumina (ILMN), ranked by their latest cash and short-term investments
| $28.12B | |
| $20.10B | |
| $14.56B | |
| $9.13B | |
| $7.27B | |
| $5.74B | |
| $5.26B | |
| $4.24B |
- $28.12B
- $20.10B
- $14.56B
- $9.13B
- $7.27B
- $5.74B
- $5.26B
- $4.24B
Frequently asked questions
Illumina (ILMN) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation